Had another read of the October news letter and spotted this.
"In addition tothe interim safety and PFS data from CAN-003, intracellular cytokine staining(ICS) results for 7 patients who completed full dosing of CVac will be released in October. TCS is a technique to evaluate if CVac has induced the desired mucin 1-specific T-cell response targeted to ovarian cancer in patients treated with CVac.ICS results will help assess the biological and immune stimulant activity of CVac and may support Prima expanding clinical development of CVac to investigate other cancer types that over-express mucin 1.
Because it wasnt listed in the schedule of events in the newsletter it raised doubts as to whether the ICS for the 7 patients was going to be delayed but the body of the newsletter on page 1 makes it clear that the results would be released this month.
Not long to go lol. I might top up again tomorrow.
cheers
ics data-7 patient cohort-october 2012
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.8¢ | 29.0¢ | $539.5K | 1.834M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 214062 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 469318 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |